Search research articles
Contact Us
Filters
Showing results (181-190 of 212) with videos related to
Page
of 22
Sort By:
Bone Marrow Transplantation
|
November 1, 2006
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
J M Hows, J R Passweg, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)
M Fopp, M F Fey, M Bacchi, et al.
Acta Haematologica
|
August 7, 1999
High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression
C Nissen, A Tichelli, A Gratwohl, et al.
Bone Marrow Transplantation
|
January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
J D Rizzo, J R Wingard, A Tichelli, et al.
Schweizerische Medizinische Wochenschrift
|
November 24, 1998
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation]
A Tichelli, D Surbek, H Huxol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)
D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Bone Marrow Transplantation
|
January 27, 2015
Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP
A Lawitschka, M Faraci, I Yaniv, et al.
Bone Marrow Transplantation
|
September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M Stern, J R Passweg, S Meyer-Monard, et al.
Leukemia
|
April 11, 2012
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy
V Dubois, F Sloan-Béna, A Cesbron, et al.
Bone Marrow Transplantation
|
March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation
A S Buser, M Stern, C Bucher, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 212) with videos related to
Sort By:
Page
of 22
Bone Marrow Transplantation
|
November 1, 2006
Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors
J M Hows, J R Passweg, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)
M Fopp, M F Fey, M Bacchi, et al.
Acta Haematologica
|
August 7, 1999
High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression
C Nissen, A Tichelli, A Gratwohl, et al.
Bone Marrow Transplantation
|
January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
J D Rizzo, J R Wingard, A Tichelli, et al.
Schweizerische Medizinische Wochenschrift
|
November 24, 1998
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation]
A Tichelli, D Surbek, H Huxol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)
D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
Bone Marrow Transplantation
|
January 27, 2015
Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP
A Lawitschka, M Faraci, I Yaniv, et al.
Bone Marrow Transplantation
|
September 4, 2012
Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
M Stern, J R Passweg, S Meyer-Monard, et al.
Leukemia
|
April 11, 2012
Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy
V Dubois, F Sloan-Béna, A Cesbron, et al.
Bone Marrow Transplantation
|
March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation
A S Buser, M Stern, C Bucher, et al.
Page
of 22